Template:Infobox drug/testcases11#(data page)

Merge {{lts|Infobox neurohormone}} into {{lts|Infobox drug}} (2017)
Add gene therapy section (2018)

This testcase page uses {{tl|Infobox drug/sandbox}}. Diff: {{DiffPages|page1=Template:Infobox drug|page2=Template:Infobox drug/sandbox|listpages=yes}}.

Testing Gene therapy{{Infobox drug/testcases/navbox|state=collapsed}}

Diff: {{DiffPages|page1=Template:Infobox drug|page2=Template:Infobox drug/sandbox|listpages=yes}}.

;Has (data page)

:Template:Infobox drug/testcases11 (data page)

:This page has a data page to test this situation. (example: Caffeine has Caffeine (data page))

(data page)

:Jan 2022: {{para|data page}}

: This testpage has DP: :Template:Infobox drug/testcases11 (data page)

:(new) {{tl|Infobox drug/data page link}}

{{para|data page}} absent (dflt)

{{testcase table

|pronounce = test (DP) -dflt

}}

{{para|data page|<blank>}}

{{testcase table

|pronounce = test (DP) -dp=blank

|data page=

}}

:{{para|data page|Water (data page)}}

{{testcase table

|pronounce = test (DP) -dp=water(DP)

|data page=Water (data page)

}}

:{{para|data page|Water (data page)}}

{{testcase table

|pronounce = test (DP) -dp=[water(DP)]

|data page=Water (data page)

}}

:{{para|data page|none}}

{{testcase table

|pronounce = test (DP) -dp=none

|data page=none

}}

other older

:{{para|data page|Water (data page)}}

{{testcase table

|name = test (data page)

|data_page = Water (data page)

| Verifiedfields = changed

| verifiedrevid = 415028406

}}

:{{para|dat_ page|Foobar (xyz page)}}

{{testcase table

|name = test (data page) 3

|data_page = Foobar (xyz page)

| Verifiedfields = changed

| verifiedrevid = 415028406

}}

Gene therapy

Pilot article is Voretigene neparvovec

{{testcase table

| type=

| drug name = Voretigene neparvovec

| gt_target_gene = RPE65

| gt_vector = adenovirus serotype 2

| gt_nucleic_acid_type = [not applicable here]

| gt_editing_method = [not applicable here]

| gt_delivery_method = [not applicable here]

}}

;2

{{testcase table

| type=

| drug name = Voretigene neparvovec

| gt_target_gene = RPE65

| gt_vector = adenovirus serotype 2

| gt_nucleic_acid_type = [not applicable here]

| gt_editing_method = [not applicable here]

| gt_delivery_method = [not applicable here]

}}

Testcase 1

;Testcase comparing the previous template (now deprecated)

style="vertical-align:top"

colspan=2 | Oxytocin

| {{tl|Infobox neurohormone}}

{{Infobox drug/sandbox

| type=

| drug_name = Oxytocin (hormone)

| IUPAC_name = 1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide

| image = Oxytocin with labels.png

| width = 250px

| source_tissues = posterior pituitary

| target_tissues = central nervous system

| receptors = oxytocin receptor

| agonists = carbetocin, demoxytocin, merotocin

| antagonists = atosiban, epelsiban, retosiban

| precursor = oxytocin-neurophysin 1

| biosynthesis = magnolysin

| metabolism = oxytocinase

| legal_US= blabla-test

| class = clinicalclass

| bioavailability =

| protein_bound = 30%

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

|{{Infobox neurohormone

| name = Oxytocin (hormone)

| alt =

| IUPACName = 1-({(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-(4-hydroxybenzyl)-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-leucylglycinamide

| synonyms =

| abbrev =

| image = Oxytocin with labels.png

| sources = posterior pituitary

| targets = central nervous system

| receptors = oxytocin receptor

| agonists = carbetocin, demoxytocin, merotocin

| antagonists = atosiban, epelsiban, retosiban

| precursor = oxytocin-neurophysin 1

| synth = magnolysin

| breakdown = oxytocinase

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

| footnotes =

}}

test metabolism in two sections

{{testcase table

| type=

| drug_name = M. with physiological data only

| IUPAC_name =

| source_tissues = posterior pituitary

| target_tissues = central nervous system

| receptors = oxytocin receptor

| agonists = carbetocin, demoxytocin, merotocin

| antagonists = atosiban, epelsiban, retosiban

| precursor = oxytocin-neurophysin 1

| biosynthesis = magnolysin

| metabolism = oxytocinase

| bioavailability =

| protein_bound =

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

{{testcase table

| type=

| drug_name = M. with pharmacokinetic data only

| IUPAC_name =

| metabolism = oxytocinase

| bioavailability = xyz

| protein_bound = 30%

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

{{testcase table

| type=

| drug_name = M. with physio and pharmacokin data both

| IUPAC_name =

| source_tissues = posterior pituitary

| target_tissues = central nervous system

| receptors = oxytocin receptor

| agonists = carbetocin, demoxytocin, merotocin

| antagonists = atosiban, epelsiban, retosiban

| precursor = oxytocin-neurophysin 1

| biosynthesis = magnolysin

| metabolism = oxytocinase

| bioavailability = xyz

| protein_bound = 30%

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

{{testcase table

| type=

| drug_name = M. with M. value only

| IUPAC_name =

| source_tissues =

| target_tissues =

| receptors =

| agonists =

| antagonists =

| precursor =

| biosynthesis =

| metabolism = oxytocinase

| bioavailability =

| protein_bound =

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

}}

text metabolism, and pronunciation

{{testcase table

| type=

| drug_name = M. with physiological data only

| IUPAC_name =

| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}

| image = Aspirin-skeletal.svg

| source_tissues = posterior pituitary

| target_tissues = central nervous system

| receptors = oxytocin receptor

| agonists = carbetocin, demoxytocin, merotocin

| antagonists = atosiban, epelsiban, retosiban

| precursor = oxytocin-neurophysin 1

| biosynthesis = magnolysin

| metabolism = oxytocinase

| bioavailability =

| protein_bound =

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

{{testcase table

| type=

| drug_name = M. with pharmacokinetic data only

| IUPAC_name =

| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}

| image = Aspirin-skeletal.svg

| metabolism = oxytocinase

| bioavailability = xyz

| protein_bound = 30%

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

{{testcase table

| type=

| drug_name = M. with physio and pharmacokin data both

| IUPAC_name =

| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}

| image = Aspirin-skeletal.svg

| source_tissues = posterior pituitary

| target_tissues = central nervous system

| receptors = oxytocin receptor

| agonists = carbetocin, demoxytocin, merotocin

| antagonists = atosiban, epelsiban, retosiban

| precursor = oxytocin-neurophysin 1

| biosynthesis = magnolysin

| metabolism = oxytocinase

| bioavailability = xyz

| protein_bound = 30%

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

| smiles = CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O

| StdInChI_Ref = {{stdinchicite|correct|chemspider}}

| StdInChI = 1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1

| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}

| StdInChIKey = XNOPRXBHLZRZKH-DSZYJQQASA-N

}}

{{testcase table

| type=

| drug_name = M. with M. value only

| IUPAC_name =

| pronounce = {{IPAc-en|ˌ|ɒ|k|s|ᵻ|ˈ|t|oʊ|s|ɪ|n}}

| image = Aspirin-skeletal.svg

| source_tissues =

| target_tissues =

| receptors =

| agonists =

| antagonists =

| precursor =

| biosynthesis =

| metabolism = oxytocinase

| bioavailability =

| protein_bound =

| CAS_number_Ref = {{cascite|correct}}

| CAS_number = 50-56-6

| C=43 | H=66 | N=12 | O=12 | S=2

| molecular_weight = 1007.19 g/mol

}}